Login
Register
Back to News
Corbus Pharmaceuticals shares are trading higher after the company reported a Q4 EPS beat.
Benzinga Newsdesk
www.benzinga.com
Positive 95.4%
Neg 0%
Neu 0%
Pos 95.4%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment